NCT01691807 - Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Cancer

Interventions

DRUG

ofatumumab

treatment for NHL

DRUG

bendamustine

treatment for NHL

Trial Locations (5)

Novartis Investigative Site, Morgantown

Novartis Investigative Site, Southaven

Novartis Investigative Site, Houston

Novartis Investigative Site, San Antonio

Novartis Investigative Site, Birmingham